Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 21, 2020; 26(7): 725-739
Published online Feb 21, 2020. doi: 10.3748/wjg.v26.i7.725
Published online Feb 21, 2020. doi: 10.3748/wjg.v26.i7.725
Table 1 Preoperative clinicopathological, liver function, and operative data of the patients
Overall (n = 215) | No postoperative liver failure (n = 188) | Postoperative liver failure (n = 27) | P value | ||
Age, yr (median) | 68 | 68 | 72 | 0.107 | |
Sex | Men | 148 | 125 | 23 | 0.073 |
Women | 67 | 63 | 4 | ||
Child-Pugh score | 5 | 180 | 162 | 18 | 0.01 |
6 | 27 | 22 | 5 | ||
7 | 7 | 3 | 4 | ||
8 | 1 | 1 | 0 | ||
Liver tumor | Hepatocellular carcinoma | 87 | 75 | 12 | 0.030 |
Colorectal metastases | 49 | 46 | 3 | ||
Hilar cholangiocarcinoma | 24 | 17 | 7 | ||
Intrahepatic cholangiocarcinoma | 20 | 16 | 4 | ||
Metastatic liver tumor (other than colorectal cancer) | 22 | 21 | 1 | ||
Other tumors | 13 | 13 | 0 | ||
Surgery | Partial resection | 112 | 103 | 9 | 0.041 |
Sectionectomy | 23 | 22 | 1 | ||
Lobectomy (+extended) | 73 | 58 | 15 | ||
Three sectionectomy | 7 | 5 | 2 |
Table 2 Preoperative levels of liver function parameters in patients with and without postoperative liver failure in univariate analysis
Factor | No postoperative liver failure | Postoperative liver failure | Univariate analysis | |
(n = 188) | (n = 27) | OR (95%CI) | P value | |
Age, yr (median) | 68 | 72 | 0.095 | |
Sex, male/female | 125/63 | 4/23 | 0.064 | |
Preoperative biliary drainage | 15 | 7 | 0.005 | |
Child-Pugh score | 5.16 ± 0.45 | 5.48 ± 0.75 | 2.505 (1.345-4.665) | 0.004 |
Blood platelet (× 104/μL) | 19.5 ± 7.7 | 16.7 ± 6.6 | 0.099 | |
Total bilirubin (mg/dL) | 0.80 ± 0.33 | 0.90 ± 0.39 | 0.099 | |
PT-INR (INR) | 1.00 ± 0.12 | 1.09 ± 0.13 | 63.56 (2.533-1595.002) | 0.012 |
Albumin (g/dL) | 4.03 ± 0.45 | 3.64 ± 0.54 | 0.210 (0.091-0.484) | < 0.001 |
Aspartate aminotransferase (IU/L) | 30.9 ± 23.6 | 40.6 ± 24.8 | 1.012 (0.999-1.025) | 0.071 |
Alanine aminotransferase (IU/L) | 27.3 ± 20.7 | 32.6 ± 24.2 | 0.171 | |
Cholinesterase (IU/L) | 284.2 ± 82.1 | 194.6 ± 69.9 | 0.982 (0.975-0.990) | < 0.001 |
Total cholesterol (mg/dL) | 188.2 ± 39.2 | 165.8 ± 37.1 | 0.984 (0.972-0.996) | 0.011 |
ICG-R15 (%) | 10.9 ± 9.01 | 14.8 ± 11.1 | 1.034 (0.998-1.071) | 0.068 |
Type IV collagen 7S (ng/mL) | 5.50 ± 1.91 | 8.80 ± 3.06 | 1.601 (1.340-1.914) | < 0.001 |
Hyaluronic acid (ng/mL) | 88.5 ± 100.6 | 256.5 ± 216.5 | 1.005 (1.001-1.009) | 0.018 |
ARFITM (v/s) | 1.56 ± 0.57 | 2.01 ± 0.69 | 2.785 (1.431-5.422) | 0.003 |
CRP (mg/dL) | 0.39 ± 1.01 | 0.82 ± 1.33 | 1.319 (0.995-1.747) | 0.054 |
Extent of hepatic resection[26] | 0.81 ± 0.97 | 1.37 ± 1.04 | 1.688 (1.114-2.557) | 0.013 |
Table 3 Preoperative liver function parameters in patients with and without post-hepatectomy liver failure in multivariate analysis
Factors | Multivariate analysis | |
OR (95%CI) | P value | |
Sex, male/female | 2.802 (0.813-9.653) | 0.0513 |
ICG-R15 (%) | 0.998 (0.951-1.047) | 0.466 |
Type IV collagen 7S (ng/mL) | 1.543 (1.258-1.892) | < 0.001 |
ARFITM (v/s) | 1.525 (0.673-3.457) | 0.156 |
Table 4 Cox proportional hazards analysis to identify predictors of postoperative recovery of liver function to achieve Child-Pugh class A
Factors | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age, yr (mean) | 0.984 (0.972-0.996) | 0.007 | 0.837 | |
Sex, male/female | 0.688 | 0.656 | ||
Child-Pugh score | 0.577 (0.427-0.780) | < 0.001 | 0.123 | |
Cholinesterase (IU/L) | 1.002 (1.001-1.003) | 0.001 | 0.346 | |
Total cholesterol (mg/dL) | 1.004 (1.001-1.007) | 0.024 | 0.932 | |
ICG-R15 (%) | 0.980 (0.964-0.997) | 0.024 | 0.756 | |
Type IV collagen 7S (ng/mL) | 0.837 (0.784-0.894) | < 0.001 | 0.779 (0.682-0.890) | < 0.001 |
Hyaluronic acid (ng/mL) | 0.996 (0.994-0.999) | 0.003 | 0.179 | |
ARFITM (v/s) | 0.651 (0.490-0.866) | 0.003 | 0.625 | |
CRP (mg/dL) | 0.792 (0.669-0.936) | 0.006 | 0.142 | |
Extent of hepatic resection[26] | 0.813 (0.707-0.936) | 0.004 | 0.64 |
Table 5 Cox proportional hazards analysis to identify predictors of postoperative recovery of liver function to achieve serum total bilirubin < 2 mg/dL
Factors | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age, yr (mean) | 0.275 | 0.53 | ||
Sex, male/female | 0.127 | 0.222 | ||
Child-Pugh score | 0.749 (0.565-0.994) | < 0.001 | 0.21 | |
PT-INR (INR) | 0.195 (0.47-0.803) | 0.024 | 0.155 | |
Cholinesterase (IU/L) | 1.002 (1.001-1.004) | 0.003 | 0.106 | |
ICG-R15 (%) | 0.165 | |||
Type IV collagen 7S (ng/mL) | 0.905 (0.851-0.926) | 0.001 | 0.906 (0.851-0.962) | 0.001 |
Hyaluronic acid (ng/mL) | 0.552 | |||
ARFITM (v/s) | 0.056 | |||
CRP (mg/dL) | 0.118 | |||
Extent of hepatic resection[26] | 0.159 |
Table 6 Cox proportional hazards analysis to identify predictors of postoperative recovery of liver function to achieve serum albumin > 2.8 g/dL
Factors | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age, yr (mean) | 0.985 (0.973-0.996) | 0.008 | 0.18 | |
Sex, male/female | 0.059 | 0.457 | ||
Child-Pugh score | 0.573 (0.424-0.776) | < 0.001 | 0.611 | |
Cholinesterase (IU/L) | 1.002 (1.001-1.003) | 0.001 | 0.39 | |
ICG-R15 (%) | 0.979 (0.962-0.996) | 0.008 | 0.983 | |
Type IV collagen 7S (ng/mL) | 0.841 (0.787-0.899) | < 0.001 | 0.759 (0.659-0.875) | < 0.001 |
Hyaluronic acid (ng/mL) | 0.996 (0.994-0.999) | 0.004 | 0.292 | |
ARFITM (v/s) | 0.723 (0.545-0.959) | 0.024 | 0.774 | |
CRP (mg/dL) | 0.808 (0.685-0.953) | 0.011 | 0.192 | |
Extent of hepatic resection[26] | 0.830 (0.722-0.955) | 0.009 | 0.636 |
Table 7 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients who did not have hepatitis viruses in univariate analysis
Factors | No postoperative liver failure | Postoperative liver failure | Univariate analysis | |
(n = 136) | (n = 22) | OR (95%CI) | P value | |
Age, yr (mean) | 65.3 | 70.7 | 0.09 | |
Sex, male/female | 87/49 | 4/18 | 0.109 | |
Preoperative biliary drainage | 9 | 4 | 0.045 | |
Child-Pugh score | 5.15 ± 0.39 | 5.59 ± 0.80 | 3.694 (1.766-7.729) | 0.001 |
Platelets (× 104/μL) | 21.1 ± 7.7 | 17.1 ± 7.0 | 0.991 | |
Total bilirubin (mg/dL) | 0.79 ± 0.33 | 0.91 ± 0.40 | 0.111 | |
PT-INR (INR) | 0.99 ± 0.13 | 1.1 ± 0.14 | 123.581 (2.637-5791.435) | 0.014 |
Albumin (g/dL) | 4.03 ± 0.44 | 3.57 ± 0.60 | 0.157 (0.059-0.414) | < 0.001 |
Aspartate aminotransferase (IU/L) | 30.8 ± 26.6 | 41.5 ± 25.9 | 0.121 | |
Alanine aminotransferase (IU/L) | 28.0 ± 22.9 | 33.6 ± 25.5 | 0.296 | |
Cholinesterase (IU/L) | 293.1 ± 85.1 | 192.2 ± 67.9 | 0.979 (0.970-0.988) | < 0.001 |
Total cholesterol (mg/dL) | 192.2 ± 42.2 | 168.4 ± 40.2 | 0.985 (0.973-0.998) | 0.02 |
ICG-15 clearance rate (%) | 10.3 ± 9.11 | 15.0 ± 11.8 | 1.034 (0.998-1.081) | 0.064 |
Type IV collagen 7S (ng/mL) | 5.36 ± 1.85 | 9.15 ± 3.13 | 1.731 (1.383-2.167) | < 0.001 |
Hyaluronic acid (ng/mL) | 78.7 ± 99.2 | 261.9 ± 207.3 | 1.005 (1.004-1.011) | < 0.001 |
ARFITM (v/s) | 1.49 ± 0.53 | 1.98 ± 0.67 | 2.785 (1.546-7.887) | 0.003 |
CRP (mg/dL) | 0.47 ± 1.14 | 1.00 ± 1.42 | 0.056 | |
Extent of hepatic resection[26] | 0.90 ± 1.0 | 1.41 ± 1.05 | 1.638 (1.037-2.587) | 0.034 |
Table 8 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients who did not have hepatitis viruses in multivariate analysis
Factors | Multivariate analysis | |
OR (95%CI) | P value | |
Cholinesterase (IU/L) | 0.987 (0.977-0.998) | 0.0083 |
ICG-R15 (%) | 0.959 (0.896-1.026) | 0.11 |
Type IV collagen 7S (ng/mL) | 1.423 (1.074-1.886) | 0.002 |
Hyaluronic acid (ng/mL) | 1.004 (1.000-1.008) | 0.021 |
ARFITM (v/s) | 1.144 (0.406-3.220) | 0.6 |
Table 9 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients who had jaundice in univariate analysis
Factors | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age, yr (mean) | 0.74 | 0.817 | ||
Sex, male/female | 0.105 | 0.237 | ||
Child-Pugh score | 0.22 | |||
Cholinesterase (IU/L) | 0.979 (0.970-0.988) | 0.066 | 0.157 | |
Total cholesterol (mg/dL) | 0.652 | |||
ICG-R15 (%) | 0.371 | |||
Type IV collagen 7S (ng/mL) | 1.540 (1.036-2.288) | 0.033 | 1.540 (1.036-2.288) | 0.033 |
Hyaluronic acid (ng/mL) | 0.187 | |||
ARFI TM (v/s) | 0.171 | |||
CRP (mg/dL) | 0.533 | |||
Extent of hepatic resection[26] | 0.481 |
Table 10 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients in univariate and multivariate analyses for 91 patients
Factors | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age, yr (mean) | 0.083 | 0.065 | ||
Sex, male/female | 0.462 | 0.557 | ||
Child-Pugh score | 0.347 | |||
Platelets (× 104/μL) | 0.509 | |||
PT-INR (INR) | 0.064 | |||
Aspartate aminotransferase (IU/L) | 0.087 | |||
Alanine aminotransferase (IU/L) | 0.468 | |||
Cholinesterase (IU/L) | 0.986 (0.977-0.995) | 0.003 | 0.348 | |
Total cholesterol (mg/dL) | 0.128 | |||
ICG-R15 (%) | 0.643 | |||
Type IV collagen 7S (ng/mL) | 1.514 (0.784-0.894) | < 0.001 | 2.178 (0.684-0.890) | 0.005 |
Hyaluronic acid (ng/mL) | 1.005 (1.001-1.009) | 0.018 | 0.674 | |
ARFITM (v/s) | 0.145 | |||
CRP (mg/dL) | 0.495 | |||
METAVIR score | 0.801 | |||
Extent of hepatic resection[26] | 2.296 (0.707-0.936) | 0.009 | 0.86 |
- Citation: Ishii M, Itano O, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Takeuchi A, Tsujikawa H, Abe T, Kitagawa Y. Pre-hepatectomy type IV collagen 7S predicts post-hepatectomy liver failure and recovery. World J Gastroenterol 2020; 26(7): 725-739
- URL: https://www.wjgnet.com/1007-9327/full/v26/i7/725.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i7.725